Neurochem's Board of Directors is composed of skilled pharmaceutical experts with proven track records in strategic sectors of the industry.

Dr. Francesco Bellini

Chairman, President and
Chief Executive Officer, Neurochem Inc.

Mr. John Bernbach

President and founder,
NTM (Not Traditional Media) Inc.

Dr. Colin Bier

Consultant

Mr. Jean-Guy Desjardins

President and Chief Executive Officer,
Centria Inc.

Mr. André Desmarais

Co-Chief Executive Officer,
Power Corporation of Canada

Mr. Neil Flanzraich

Consultant

Mr. Peter Kruyt

President,
Power Technology Investment Corporation

Mr. François Legault

President & COO
Virochem Pharma Inc.

Mr. John Molloy

President and Chief Executive Officer,
Parteq Research and Development Innovations,
Queen's University

Mr. Calin Rovinescu

Senior Principal,
Genuity Capital Markets

Mr. Graeme K. Rutledge

Consultant

Dr. Emil Skamene

Scientific Director,
McGill University Health Centre

Our site is best viewed with IE4+ at a resolution of 1024×768.
All contents copyright © 1998-2007 Neurochem Inc.
Terms, Conditions and Legal Notice.